chart daily, page-2268

The RAC strategy was good. It is clear plans....with 1 drug.

There is a clear path with BIT now.
There is a strategy and achievable quickly.
But BIt has over 200+ drugs within the platform.

BIT225, a genuine covid19 contender based on its HIV immunity restoration results.
There is more recognition that restoring immunity can protect patients from
covid19 disease and assist recovery faster.
...and disrupt/kill the Delta strain.

CTAP has been setup to assist fasttracking and there is funding available from a
motivated US government.

BIT225 will be funded by the US government for the covid19 trials...with Delta and Omicron on the doorstep.
Fastrack here we come.